Oramed Pharmaceuticals earnings were -$19.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ORMP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$10.2M, down 48.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORMP reported annual earnings of -$19.1M, with -445% growth. The next ORMP earnings date is May 7, 2025.
Oramed Pharmaceuticals Earnings Reports & History FAQ
What were Oramed Pharmaceuticals's earnings last quarter?
On ORMP's earnings call on Invalid Date, Oramed Pharmaceuticals (NASDAQ: ORMP) reported Q4 2024 earnings per share (EPS) of -$0.26, up 178.79% year over year. Total ORMP earnings for the quarter were -$10.19 million. In the same quarter last year, Oramed Pharmaceuticals's earnings per share (EPS) was $0.33.
The next ORMP earnings call is Invalid Date. Add ORMP to your watchlist to be reminded of Oramed Pharmaceuticals's next earnings date.
Is Oramed Pharmaceuticals profitable or losing money?
As of the last Oramed Pharmaceuticals earnings report, Oramed Pharmaceuticals is currently losing money. Oramed Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$19.06 million, a 444.98% decrease year over year.
What was ORMP's earnings growth in the past year?
As of Oramed Pharmaceuticals's earnings date in Invalid Date, Oramed Pharmaceuticals's earnings has grown year over year. ORMP earnings in the past year totalled -$19.06 million.
What are Oramed Pharmaceuticals's earnings expectations?
The current EPS estimate for Oramed Pharmaceuticals's earnings report in Invalid Date is -$0.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.